Replies to post #67492 on Biotech Values

[DewDiligence]

Without approval of the new plant, GENZ won’t be able to increase the number of patients served, but anyone who’s receiving drug now will continue to receive it.

[genisi]

Read the questions part to the panel. There are 3 options mentioned about this.

http://www.fda.gov/ohrms/dockets/ac/08/questions/2008-4389q1-draft.pdf